CRISPR Therapeutics AG (CRSP)
60.81
+6.08
(+11.11%)
USD |
NASDAQ |
Jan 22, 16:00
61.00
+0.19
(+0.31%)
After-Hours: 04:11
CRISPR Therapeutics Cash from Investing (Quarterly): -119.23M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | -117.00M |
| Intellia Therapeutics, Inc. | -0.741M |
| Beam Therapeutics, Inc. | 65.66M |
| Novartis AG | -858.23M |
| BeOne Medicines Ltd. | -49.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -84.63M |
| Cash from Financing (Quarterly) | 296.77M |
| Free Cash Flow | -303.14M |
| Free Cash Flow Per Share (Quarterly) | -0.9277 |
| Free Cash Flow to Equity (Quarterly) | -80.28M |
| Free Cash Flow to Firm (Quarterly) | -84.71M |
| Free Cash Flow Yield | -5.70% |